Aravive Inc (NASDAQ:ARAV)
| 1.69 Delayed Data As of May 31 |  +0.06 / +3.68%Today’s Change | 0.58 Today|||52-Week Range 2.46 | +28.03% Year-to-Date |
Latest ARAV News | Press Releases
No recent news for Aravive Inc.
Today’s Trading
| Previous close | 1.63 |
| Today’s open | 1.64 |
| Day’s range | 1.57 - 1.70 |
| Volume | 8,971 |
| Average volume (3 months) | 271,535 |
| Market cap | $88.3M |
Data as of 4:00pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | -7.57% |
| Earnings growth (this year) | +41.17% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +22.78% |
| P/E ratio | NM |
| Price/Sales | 5.25 |
| Price/Book | 8.28 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ANIXAnixa Biosciences In... | -0.09 | -2.85% |
| LPTXLeap Therapeutics In... | +0.08 | +10.41% |
| ---- | ||
| DTILPrecision BioScience... | -0.10 | -11.90% |
Data as of 4:00pm ET, 05/31/2023
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $9.1M |
| Annual profit (last year) | -$76.3M |
| Net profit margin | -835.31% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Houston, Texas |
Forecasts
